ConductScience.org, home

Paper23973508

Effects of mycophenolic acid-glucosamine conjugates on the base of kidney targeted drug delivery.

Wang X and 5 others. Int J Pharm, 2013. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Effects of mycophenolic acid-glucosamine conjugates on the base of kidney targeted drug delivery. Papers, record 23973508. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23973508

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of mycophenolic acid-glucosamine conjugates on the base of kidney targeted drug delivery.
PubMed
Journal
Int J Pharm
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
0.75
iCite
Revised in PubMed
2013-09-17
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang XXiaohong
2Lin YYan
3Zeng YYingchun
4Sun XXun
5Gong TTao
6Zhang ZZhirong

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug Delivery SystemsMajor topic
GlucosamineMajor topic
KidneyMajor topic
Mycophenolic AcidMajor topic
Reperfusion InjuryMajor topic
Animals
Biological Availability
Blood Urea Nitrogen
Cell Line
Cell Survival
Creatinine
Humans
Male
Mice
Rats
Rats, Sprague-Dawley
Tissue Distribution

Source PubMed

Download CSV of topics

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
42823964A biomaterials roadmap from retinoic acid biology to kidney regenerative therapy.iScience2026https://conductscience.org/library/papers/42823964PubMed
41394960Protein O-GlcNAcylation in Health and Diseases.MedComm (2020)2025https://conductscience.org/library/papers/41394960PubMed
38560369Targeted therapy of kidney disease with nanoparticle drug delivery materials.Bioact Mater2024https://conductscience.org/library/papers/38560369PubMed
35652363Novel Drug Delivery Technologies and Targets for Renal Disease.Hypertension2022https://conductscience.org/library/papers/35652363PubMed
32226527Effective delivery of mycophenolic acid by oxygen nanobubbles for modulating immunosuppression.Theranostics2020https://conductscience.org/library/papers/32226527PubMed
28848346Renal-targeted delivery of triptolide by entrapment in pegylated TRX-20-modified liposomes.Int J Nanomedicine2017https://conductscience.org/library/papers/28848346PubMed
26316700RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer.Drug Des Devel Ther2015https://conductscience.org/library/papers/26316700PubMed
26290372Human anti-α3(IV)NC1 antibody drug conjugates target glomeruli to resolve nephritis.Am J Physiol Renal Physiol2015https://conductscience.org/library/papers/26290372PubMed
26121684Current progress in nanotechnology applications for diagnosis and treatment of kidney diseases.Adv Healthc Mater2015https://conductscience.org/library/papers/26121684PubMed
25667657Preparation of a liposomal delivery system and its in vitro release of rapamycin.Exp Ther Med2015https://conductscience.org/library/papers/25667657PubMed
25584804Diverse origins of the myofibroblast—implications for kidney fibrosis.Nat Rev Nephrol2015https://conductscience.org/library/papers/25584804PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23973508

GET https://conductscience.org/api/papers/v1/23973508/authors